Skip to content

Facioscapulohumeral Muscular Dystrophy 1 C5399970

Published: July 22, 2026Updated: August 25, 2026

Facioscapulohumeral muscular dystrophy is a genetic muscle disorder affecting face, shoulder, and arm muscles, typically beginning in teens or young adults. Progression varies widely. Treatment includes physical therapy and supportive care to maintain function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Progressive shoulder girdle weakness

(musculoskeletal)

Facial muscle weakness affecting expression

(musculoskeletal)

Scapular winging when arm is raised

(musculoskeletal)

Difficulty raising arms overhead

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Muscle Strengthening Program

Structured physical therapy focusing on gentle strengthening exercises for affected muscle groups, particularly facial, shoulder, and upper arm muscles to maintain function and delay progression.

physical_therapy
3

Cardiac and Respiratory Monitoring

Regular cardiac evaluations including ECGs and echocardiograms, plus respiratory function testing to detect cardiac involvement and respiratory muscle weakness early.

monitoring

Additional treatment options

Symptom Management

Pharmacological management of associated symptoms such as myotonia, pain, or inflammation using appropriate medications under specialist supervision.

medication

Energy Conservation Techniques

Teaching patients energy conservation and pacing strategies to manage fatigue, including scheduling rest periods and prioritizing essential activities.

lifestyle

Assistive Devices

Provision and training with appropriate assistive devices such as ankle-foot orthotics, walking aids, or adaptive equipment to maintain mobility and independence.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Facioscapulohumeral Muscular Dystrophy 1 C5399970?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Tawil R, Van Der Maarten S, Kissel JT, et al. Consensus statement on the standard of care for facioscapulohumeral muscular dystrophy. Neurology. 2021;96(8):e1021-e1033.

guideline2021
2

Deenen JC, Horlings CG, Vershuuren JJ, et al. The epidemiology of neuromuscular disorders: A systematic review. Neuromuscular Disorders. 2019;29(2):85-98.

review2019
3

Lemmers RJ, Goeman JJ, van der Vliet PJ, et al. Allele-specific DNA methylation in FSHD: A clinical trial study. Nature Genetics. 2020;52(4):398-405.

clinical_trial2020
4

Ganesan G, Jagatheeshpani M, Ramasamy K. Emerging therapeutic targets for facioscapulohumeral muscular dystrophy. Current Opinion in Neurology. 2022;35(5):647-655.

review2022

Medication Comparisons

Compare medications used to treat Facioscapulohumeral Muscular Dystrophy 1 C5399970. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy